9-35615952-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001782.3(CD72):c.679G>A(p.Gly227Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,612,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001782.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD72 | NM_001782.3 | c.679G>A | p.Gly227Ser | missense_variant | 5/9 | ENST00000259633.9 | NP_001773.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD72 | ENST00000259633.9 | c.679G>A | p.Gly227Ser | missense_variant | 5/9 | 1 | NM_001782.3 | ENSP00000259633 | P1 | |
CD72 | ENST00000490239.5 | n.1060G>A | non_coding_transcript_exon_variant | 4/8 | 1 | |||||
CD72 | ENST00000463720.5 | n.787G>A | non_coding_transcript_exon_variant | 5/5 | 3 | |||||
CD72 | ENST00000477364.5 | n.681G>A | non_coding_transcript_exon_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151784Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251068Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135728
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460892Hom.: 0 Cov.: 33 AF XY: 0.0000289 AC XY: 21AN XY: 726782
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151784Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74112
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at